Finance

Roʻyxatlar
Nega 532834 oshdi 6,63%?
Batafsil oʻrganish
532834:BOM
Camlin Fine Sciences Ltd
96,00 ₹
+6,63%
(+5,97) 1K
16-okt, 15:30:00 (GMT+5:30)  ·   INR
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
532834 tikeri uchun statistika yaratilmoqda...
Ochish
89,52 ₹
Yuqori
98,00 ₹
Past
89,43 ₹
Bozor kapitali
18,42 mlrd
Oʻrtacha hajm
45,48 ming
Hajmi
204,63 ming
P/E koeffitsiyenti
338,86
52 haftalik eng yuqori
204,35 ₹
52 haftalik eng past
88,27 ₹
Aksiya boʻyicha daromad
0,28 ₹
Muomaladagi aksiyalar
121,25 mln
Xodimlar soni
674
Ochish
89,52 ₹
Yuqori
98,00 ₹
Past
89,43 ₹
Bozor kapitali
18,42 mlrd
Oʻrtacha hajm
45,48 ming
Hajmi
204,63 ming
P/E koeffitsiyenti
338,86
52 haftalik eng yuqori
204,35 ₹
52 haftalik eng past
88,27 ₹
Aksiya boʻyicha daromad
0,28 ₹
Muomaladagi aksiyalar
121,25 mln
Xodimlar soni
674
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Camlin Fine Sciences originated as part of the Camlin group, an Indian manufacturer of stationery and art materials. The company subsequently expanded into the specialty chemicals sector, focusing on antioxidant ingredients and related chemical products. During the 2000s and 2010s, the company expanded its international operations through acquisitions and investments in overseas manufacturing facilities. These activities increased the company's presence in Europe and Latin America and broadened its product portfolio. In 2015, Camlin Fine Sciences acquired a controlling interest in Dresen Química, a Brazilian manufacturer of food preservation and shelf-life extension products. The acquisition expanded the company's operations in South America. The company later expanded its activities in aroma chemicals and vanillin production through investments in manufacturing facilities and related businesses. Company manufactures chemicals to improve the shelf life of food and other products like aromatic compounds, and performance chemicals. CFS has emerged as the largest producer of food antioxidants such as tert-Butylhydroquinone and Butylated hydroxyanisole. Wikipedia
Camlin Fine Sciences Ltd haqida
CEO-
Xodimlar soni674
Asos solingan1931
Bosh ofislar-
SektorSpeciality chemicals
Veb-saytcamlinfs.com
Oxirgi hisobot
11-avg, 2026
Moliya davri
Ch.1 2027
-0,99 ₹ / 0,12 ₹
-921,17%manfiy
Taxminiy daromad (INR)
5,20 mlrd / 5,11 mlrd
+1,66%musbat
Q1 2027 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – INR
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – INR
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
4,60 mlrd
4,57 mlrd
3,83 mlrd
5,20 mlrd
Sotilgan mahsulotning tannarxi
2,47 mlrd
2,48 mlrd
2,24 mlrd
3,06 mlrd
Daromad narxi
2,47 mlrd
2,48 mlrd
2,24 mlrd
3,06 mlrd
Tadqiqot va ishlanmalarga xarajatlar
-
-
-
-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
602,93 mln
637,64 mln
886,99 mln
734,29 mln
Operatsion xarajatlar
1,99 mlrd
2,04 mlrd
1,52 mlrd
2,16 mlrd
Jami operatsion xarajatlar
4,45 mlrd
4,52 mlrd
3,76 mlrd
5,21 mlrd
Operatsion daromad
145,85 mln
53,04 mln
65,46 mln
-15,12 mln
Boshqa nooperatsion daromad
17,20 mln
29,36 mln
-94,79 mln
13,40 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-923,00 ming
-278,54 mln
2,25 mln
-322,59 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-923,00 ming
-103,43 mln
94,48 mln
-211,49 mln
Daromad soligʻi boʻyicha xarajat
59,12 mln
452,00 ming
-64,02 mln
-4,63 mln
Amaldagi soliq stavkasi
-6 405,31%
-0,16%
-2 849,31%
1,44%
Boshqa operatsion xarajatlar
1,19 mlrd
1,23 mlrd
449,93 mln
1,23 mlrd
Sof foyda
-143,84 mln
-362,30 mln
882,02 mln
-317,06 mln
Sof foyda marjasi
-3,13%
-7,92%
23,05%
-6,10%
Har bir aksiya foydasi
-0,29
-0,94
0,76
-0,99
Foizlar va investitsiyalardan olingan daromadlar
-
-
79,64 mln
-
Foizlarni toʻlash xarajatlari
-152,05 mln
-183,29 mln
-76,78 mln
-162,78 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-152,05 mln
-183,29 mln
2,86 mln
-162,78 mln
Amortizatsiya ajratmalari
188,27 mln
167,28 mln
184,44 mln
191,56 mln
EBITDA
324,59 mln
203,20 mln
199,10 mln
118,52 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari